RxDoctor Payments Data

Kenrick Lam, MD

Orthopaedic Surgery · Chico, CANPI 1366891657

Payments from drug & device makers

What this record shows

This record is dominated by grants: $10,000 of the $16,061 with a category attached, or 62.3%. Arthrex accounts for 62.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $10,961 and has fallen 99.2% since, to $82 in 2025.

$16,061in general payments, 2019–2025

Across 61 payments — averaging $263.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Stryker$3K
  • Synthes GmbH$961
  • Medinc Of Texas$848
  • Zimmer Biomet$588
  • Johnson & Johnson$241
  • plus $313 from 6 others
$102in research payments, 2019–2025

Across 1 payment — averaging $102.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$102

What the payments were for

  • Grants$10,00062%
  • Travel & lodging$2,15413%
  • Food & beverage$3,05919%
  • Education$8485%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,061 in reported general payments places this provider in the 75th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$141,893
Medicare patients
254
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl12$43

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chico

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →